Diagnamed Holdings Corp

XCNQ:DMED (Canada)  
C$ 0.03 (0%) Dec 24
At Loss
Market Cap:
C$ 2.00M ($ 1.40M)
Enterprise V:
C$ 1.83M ($ 1.27M)
Volume:
5.00K
Avg Vol (2M):
205.83K
Trade In:
Volume:
5.00K
At Loss

Business Description

Description
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -0.35
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.8
9-Day RSI 50.45
14-Day RSI 50.97
6-1 Month Momentum % -33.33
12-1 Month Momentum % -33.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.74
Quick Ratio 0.74
Cash Ratio 0.63

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
ROE % -283.13
ROA % -114.33
ROCE % -385.79

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -2.2
EV-to-EBITDA -2.2
EV-to-FCF -2.81
Earnings Yield (Greenblatt) % -45.45
FCF Yield % -32.48

Financials

XCNQ:DMED's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Diagnamed Holdings Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.015
Beta 0
Volatility % 135.78
14-Day RSI 50.97
14-Day ATR (C$) 0.004282
20-Day SMA (C$) 0.0245
12-1 Month Momentum % -33.33
52-Week Range (C$) 0.005 - 0.07
Shares Outstanding (Mil) 80.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diagnamed Holdings Corp Filings

Filing Date Document Date Form
No Filing Data

Diagnamed Holdings Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Diagnamed Holdings Corp Frequently Asked Questions

What is Diagnamed Holdings Corp(XCNQ:DMED)'s stock price today?
The current price of XCNQ:DMED is C$0.03. The 52 week high of XCNQ:DMED is C$0.07 and 52 week low is C$0.01.
When is next earnings date of Diagnamed Holdings Corp(XCNQ:DMED)?
The next earnings date of Diagnamed Holdings Corp(XCNQ:DMED) is .
Does Diagnamed Holdings Corp(XCNQ:DMED) pay dividends? If so, how much?
Diagnamed Holdings Corp(XCNQ:DMED) does not pay dividend.

Press Release

Subject Date
No Press Release